The Pathogenesis of Primary Cicatricial Alopecias

    October 2010 in “ The American Journal of Pathology
    Matthew Harries, Ralf Paus
    Image of study
    TLDR The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.
    The document from November 2010 reviews the pathogenesis of primary cicatricial alopecias (PCAs), which are disorders causing permanent hair loss due to the destruction of hair follicle stem cells, often linked to autoimmune disease. It discusses the classification of PCAs based on inflammatory cells and the lack of understanding of the signaling pathways leading to immune attacks on hair follicle stem cells. The review emphasizes the need for further research to develop effective treatments and to understand the immunopathology of epithelial stem cells. It also explores the role of immune privilege collapse, CD200 expression loss, cell-mediated cytotoxicity, proinflammatory responses, apoptosis, sebaceous gland dysfunction, and PPARγ deficiency in PCA pathogenesis. The document suggests that PPAR-γ agonists may be promising for PCA therapy and highlights the potential role of environmental triggers, genetic factors, and stress-induced inflammation in PCA development. It concludes with a call for more attention to PCAs from researchers to improve diagnosis and treatment, and suggests a potential reclassification of PCAs based on molecular pathways.
    Discuss this study in the Community →

    Research cited in this study

    16 / 16 results

    Related Community Posts Join

    6 / 315 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 7 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Losing Hair on Dutasteride? You might have LPP

      in Research/Science  94 upvotes 1 week ago
      Men with hair loss might have lichen planopilaris (LPP), which can mimic androgenetic alopecia, leading to misdiagnosis and ineffective treatment with finasteride or dutasteride. Proper diagnosis, including biopsies, is crucial to distinguish between androgenetic alopecia and conditions like LPP.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 10 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

    Related Research

    7 / 7 results